Bcl2L13 is a ceramide synthase inhibitor in glioblastoma

Samuel A. Jensen, Andrea E. Calvert, Giora Volpert, Fotini M. Kouri, Lisa A. Hurley, Janina P. Luciano, Yongfei Wu, Alexandra Chalastanis, Anthony H. Futerman, Alexander H. Stegh*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Bcl2L13 is a ceramide synthase inhibitor in glioblastoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology